Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...

Walgreen Co., Kroger Co., and Albertsons Cos. Inc. accused two pharmaceutical companies Tuesday of conspiring to delay the generic version of a drug to treat gastroesophageal reflux disease and ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Harmony Biosciences (HRMY) announced the appointment of Adam Zaeske as executive VP and chief commercial officer, effective March 31. The ...

In previous years, Takeda Pharmaceutical Co. would draw attention to Rare Disease Day on the last day of February by doing the usual things that drug companies do: host podcasts and panel ...

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

Rio Takeda of Japan shot a 3-under 69 to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s southern island of Hainan.

Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA's Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young Japanese. The 21-year-old ...

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology. Takeda will pay ...